Literature DB >> 16381671

Tissue distribution and ontogeny of organic cation transporters in mice.

Yazen Alnouti1, Jay S Petrick, Curtis D Klaassen.   

Abstract

Organic cation transporters (Octs) play an important role in transporting cationic xeno- and endobiotics across biological membranes. Little is known about Octs in mice; therefore, the tissue distribution and developmental changes in the mRNA expression of Octs in mice were quantified. Oct1, Oct2, Oct3, Octn1, Octn2, and Octn3 mRNA expression was quantified in 14 tissues from male and female mice using the branched DNA signal amplification assay. Oct1 mRNA expression was highest in kidney, followed by liver. Oct2 mRNA was almost exclusively expressed in kidney, with male mice having twice that in female mice. The higher expression of Oct2 in male mice is due to testosterone. Oct3 mRNA was most highly expressed in placenta, ovary, and uterus, but was expressed at low levels in most tissues. Octn1 and Octn2 mRNA expression was similar, with the highest levels in kidney followed by small intestine. Octn3 mRNA was almost exclusively expressed in testes. The developmental expression of Oct1, Oct2, Octn1, and Octn2 mRNA in kidneys as well as Oct1 in liver was determined in young mice. Ontogenic expression data indicate that each of the Octs approached adult expression levels by about 3 weeks of age. The gender difference in Oct mRNA expression did not become apparent until day 30 after birth. The differences in tissue distribution of the Octs may play an important role in drug disposition to various tissues. Furthermore, low expression of the Octs in young animals may affect the pharmacokinetic behavior of drugs compared with that in adults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16381671     DOI: 10.1124/dmd.105.006932

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  51 in total

1.  NHE2X3 DKO mice exhibit gender-specific NHE8 compensation.

Authors:  Hua Xu; Jing Li; Rongji Chen; Bo Zhang; Chunhui Wang; Nolan King; Huacong Chen; Fayez K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

2.  Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Sunny Lihua Cheng; Theo K Bammler; Bhagwat Prasad; Marc Vrana; Curtis Klaassen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

3.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

4.  Adaptive hepatic and intestinal alterations in mice after deletion of NADPH-cytochrome P450 Oxidoreductase (Cpr) in hepatocytes.

Authors:  Xingguo Cheng; Jun Gu; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2014-08-21       Impact factor: 3.922

Review 5.  Molecular targets of epigenetic regulation and effectors of environmental influences.

Authors:  Supratim Choudhuri; Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-08       Impact factor: 4.219

6.  Energy restriction does not compensate for the reduced expression of hepatic drug-processing genes in mice with aging.

Authors:  Yu-Kun Jennifer Zhang; Kurt W Saupe; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2010-04-09       Impact factor: 3.922

Review 7.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

8.  Pharmacokinetics of metformin during pregnancy.

Authors:  Sara Eyal; Thomas R Easterling; Darcy Carr; Jason G Umans; Menachem Miodovnik; Gary D V Hankins; Shannon M Clark; Linda Risler; Joanne Wang; Edward J Kelly; Danny D Shen; Mary F Hebert
Journal:  Drug Metab Dispos       Date:  2010-01-29       Impact factor: 3.922

9.  Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.

Authors:  Giuliano Ciarimboli; Dirk Deuster; Arne Knief; Michael Sperling; Michael Holtkamp; Bayram Edemir; Hermann Pavenstädt; Claudia Lanvers-Kaminsky; Antoinette am Zehnhoff-Dinnesen; Alfred H Schinkel; Hermann Koepsell; Heribert Jürgens; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

10.  Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules.

Authors:  Eberhard Schlatter; Philipp Klassen; Vivian Massmann; Svenja K Holle; Denise Guckel; Bayram Edemir; Hermann Pavenstädt; Giuliano Ciarimboli
Journal:  Pflugers Arch       Date:  2014-08       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.